PROGENICS PHARMACEUTICALS, INC. Non-Qualified Stock Option Agreement Option Certificate Number:

Contract Categories: Business Finance - Stock Agreements
EX-10.1 3 b404018_ex10-1.htm NON-QUALIFIED STOCK OPTION AGREEMENT Prepared and filed by St Ives Burrups
Option Certificate Number: Certif. #
Optionee: Name
Page 1
Exhibit 10.1

PROGENICS PHARMACEUTICALS, INC.
Non-Qualified Stock Option Agreement
Option Certificate Number:

     This agreement is made of this Issue date by and between Progenics Pharmaceuticals, Inc., a Delaware corporation, including any of its subsidiaries (the “Company”) and Name (the “Optionee”).

Specific Terms of the Option

     Subject to the terms and conditions hereinafter set forth and the terms and conditions of the Progenics Pharmaceuticals, Inc. Amended 1996 Stock Incentive Plan (the “Plan”), Progenics Pharmaceuticals, Inc., a Delaware corporation (the “Company”) hereby grants the Optionee the following option to purchase Common Stock, par value $0.0013 per share (the “Stock”) of the Company.

1. Date of Grant of Option: Issue date
     
2. An Option for # Shares shares of COMMON stock (the “Stock”)
     
3. Option Exercise Price (per share): Price
     
4. Term of Option: Subject to Section 8, this Option expires Expiry date at 5:00 p.m. Eastern Time.
     
5. Exercise Schedule: Provided that on the dates set forth below the Optionee is still employed by the Company or, if the Optionee is not employed by the Company the Optionee is still actively involved in the Company (as determined by the Board of Directors), the Option will become exercisable as follows and as provided in Section 8 below:
   
   
Date
on or after
Total Option Shares Subject to Exercise
Incremental Cumulative
Date 1 Vest 1 Vest 1
Date 2 Vest 1 Vest 2
Date 3 Vest 1 Vest 3
Date 4 Vest 1 Vest 4
Date 5 Vest 1 # Shares

OPTIONEE’S SIGNATURE: ______________________________________ DATE: ____________

  Optionee’s address: Name
    Street
    City, St & zip
     
  Optionee’s Social Security Number: SS #

 

 


Back to Contents

Option Certificate Number: Certif. #
Optionee: Name
Page 2
 

 

OTHER TERMS OF THE OPTION

     WHEREAS, the Company has instituted a program entitled “Progenics Pharmaceuticals, Inc. Amended 1996 Stock Incentive Plan”

     WHEREAS, the Board of Directors (“the Board”) has authorized the grant of stock options upon certain terms and conditions set forth below; and

     WHEREAS, the Board has authorized the grant of this stock option pursuant and subject to the terms of the Plan, a copy of which is available from the Company and is hereby incorporated herein;

     NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements herein contained, the Company and the Optionee agree as set forth on the first page hereof and as follows:

     6.      Grant. Pursuant and subject to the Plan, the Company does hereby grant to the Optionee a non-qualified stock option (the “Option”) to purchase from the Company the number of shares of its Common Stock, $.0013 par value per share (“Stock”) set forth in Section 2 on the first page hereof upon the terms and conditions set forth in the Plan and upon the additional terms and conditions contained herein. This Option is a non-qualified stock option and is not intended to qualify for special federal income tax treatment as an “incentive stock option” pursuant to Section 422A of the Internal Revenue Code of 1986, as amended.

          7.      Option Price. This Option may be exercised at the option price per share of Stock set forth in Section 3 on page 1 hereof, subject to adjustment as provided herein and in the Plan.

          8.      Term and Exercisability of Option. This Option shall expire on the date determined pursuant to Section 4 on page 1 hereof and shall be exercisable prior to that date in accordance with and subject to the conditions set forth in the Plan and those conditions, if any, set forth in Section 5 on page 1 hereof. In addition, in the event that before this Option has been exercised in full, the Optionee ceases to be an employee of the Company for any reason other than death or a termination for dishonesty or other “cause” as provided in Section 6.5 of the Plan, the Optionee may exercise this Option to the extent that he might have exercised it on the date of termination of his employment, during the period ending on the earlier of (i) the date on which the Option expires in accordance with Section 4 of this Agreement or (ii) three months after the date of termination of the Optionee’s employment by the Company. In the event of the death of the Optionee before this Option has been exercised in full, the personal representative of the Optionee may exercise this Option to the extent that the Optionee might have exercised it on the date of his death, during the period ending on the earlier of (i) the date on which the Option expires in accordance with Section 4 of this Agreement or (ii) the first anniversary of the date of the Optionee’s death.

     9.      Method of Exercise. To the extent that the right to purchase shares of Stock has accrued hereunder, this Option may be exercised from time to time by written notice to the Company in the form attached hereto as Exhibit 1, stating the number of shares with respect to which this Option is being exercised, and accompanied by payment in full of the option price for the number of shares to be delivered by means of payment acceptable to the Company in accordance with Section 6.3 of the Plan. As soon as practicable after its receipt of such notice, the Company shall, without transfer or issue tax to the Optionee (or other person entitled to exercise this Option), deliver to the Optionee (or other person entitled to exercise this Option), at the principal executive offices of the Company or such other place as shall be mutually acceptable, a certificate or certificates for such shares out of theretofore authorized but unissued shares or reacquired shares of its Stock as the Company may elect; provided, however, that the time of such delivery may be postponed by the Company for such period as may be required for it with reasonable diligence to comply with any applicable requirements of law. Payment of the option price may be made in cash or cash equivalents, or, in accordance with the terms and conditions of Section 6.3 of the Plan, in whole or in part in shares of Common Stock of the Company; provided, however, that the Board reserves the right upon receipt of any written notice of exercise from the Optionee to require payment in cash with respect to the shares contemplated in such notice. If the Optionee (or other person entitled to exercise this Option) fails to pay for and accept delivery of all of the shares specified in such notice upon tender of delivery thereof, his right to exercise this Option with respect to such shares not paid for may be terminated by the Company.

 


Back to Contents

Option Certificate Number: Certif. #
Optionee: Name
Page 3
 

 

     10.      Withholding Taxes. The Optionee hereby agrees, as a condition to any exercise of this Option, to provide to the Company an amount sufficient to satisfy its obligation to withhold certain federal, state and local taxes arising by reason of such exercise (the “Withholding Amount”) by (a) authorizing the Company to withhold the Withholding Amount from his cash compensation, or (b) remitting the Withholding Amount to the Company in cash; provided that to the extent that the Withholding Amount is not provided by one or a combination of such methods, the Company in its discretion may refuse to issue such Stock or may withhold from the Stock delivered upon exercise of this Option that number of shares having a fair market value, on the date of exercise, sufficient to eliminate any deficiency in the Withholding Amount.

     11.      Transferability. Solely to the extent approved by the Compensation Committee of the Company’s Board of Directors this option may be transferred to members of the Optionee’s immediate family, charitable institutions, or trusts or partnerships whose beneficiaries are any of the foregoing, and/or to such persons or entities as may be approved by the Committee, subject to the condition that the Committee be satisfied that such transfer is being made for estate or tax planning purposes or for gratuitous purposes, without consideration (other than nominal consideration) being received therefore.

     12.      Compliance with Securities Act. The Company shall not be obligated to sell or issue any shares of Stock or other securities pursuant to the exercise of this Option unless the shares of Stock or other securities with respect to which this Option is being exercised are at that time effectively registered or exempt from registration under the Securities Act of 1933, as amended, and applicable state securities laws. In the event shares or other securities shall be issued which shall not be so registered, the Optionee hereby represents, warrants and agrees that he will receive such shares or other securities for investment and not with a view to their resale or distribution, and will execute an appropriate investment letter satisfactory to the Company and its counsel.

     13.      Legends. The Optionee hereby acknowledges that the stock certificate or certificates evidencing shares of Stock or other securities issued pursuant to any exercise of this Option will bear a legend setting forth the restrictions on their transferability described in Section 12 hereof and, if applicable to this Option, in Section 13.4 of the Plan.

     14.      Rights as Stockholder. The optionee shall have no rights as a stockholder with respect to any shares covered by this Option until the date of issuance of a stock certificate to him for such shares. No adjustment shall be made for dividends or the rights for which the record date is prior to the date such stock certificate is issued.

     15.      Termination or Amendment of Plan. The Board of Directors may terminate or amend the Plan at any time, but no such termination or amendment will affect rights and obligations under this Option.

     16.      Effect Upon Employment. Nothing in this Option or the Plan shall be construed to impose any obligation upon the Company to employ the Optionee or to retain the Optionee in its employ.

     17.      Time for Acceptance. Unless the Optionee shall evidence his acceptance of this Option by execution of this Agreement within seven (7) days after its delivery to him, the Option and this Agreement shall be null and void.

     18.      General Provisions.

     A.      Amendment; Waivers. This Agreement, including the Plan, contains the full and complete understanding and agreement of the parties hereto as to the subject matter hereof and may not be modified or amended, nor may any provision hereof be waived, except by a further written agreement duly signed by each of the parties. The waiver by either of the parties hereto of any provision hereof in any instance shall not operate as a waiver of any other provision hereof or in any other instance.

     B.      Binding Effect. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective heirs, executors, administrators, representatives, successors and assigns.

 


Back to Contents

Option Certificate Number: Certif. #
Optionee: Name
Page 4
 

 

     C.      Construction. This Agreement is to be construed in accordance with the terms of the Plan. In case of any conflict between the Plan and this Agreement, the Plan shall control. The titles of the sections of this Agreement and of the Plan are included for convenience only and shall not be construed as modifying or affecting their provisions. The masculine gender shall include both sexes; the singular shall include the plural and the plural the singular unless the context otherwise requires.

     D.      Notices. Any notice in connection with this Agreement shall be deemed to have been properly delivered if it is in writing and is delivered in hand or sent be registered mail to the party addressed as follows, unless another address has been substituted by notice so given:

 

  To the Optionee: To his address as listed on the books of the Company.
     
  To the Company: Progenics Pharmaceuticals, Inc.
    777 Old Saw Mill River Road
Tarrytown, NY 10591
Attn: Treasurer